Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study

Cancer Treat Rep. 1982 Aug;66(8):1667-8.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Drug Evaluation
  • Female
  • Germanium / adverse effects
  • Germanium / therapeutic use*
  • Humans
  • Middle Aged
  • Organometallic Compounds*
  • Spiro Compounds / adverse effects
  • Spiro Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Organometallic Compounds
  • Spiro Compounds
  • Germanium
  • spirogermanium